| The GM2 activator protein, a novel inhibitor of platelet-activating factor. | |
| | |
MedLine Citation:
|
PMID: 10329374 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The GM2 activator protein is required as a substrate-specific cofactor for beta-hexosaminidase A to hydrolyze GM2 ganglioside. The GM2 activator protein reversibly binds and solubilizes individual GM2 ganglioside molecules, making them available as substrate. Although GM2 ganglioside is the strongest binding ligand for the activator protein, it can also bind and transport between membranes a series of other glycolipids, even at neutral pH. Biosynthetic studies have shown that a large portion of newly synthesized GM2 activator molecules are not targeted to the lysosome, but are secreted and can then be recaptured by other cells through a carbohydrate independent mechanism. Thus, the GM2 activator protein may have other in vivo functions. We found that the GM2 activator protein can inhibit, through specific binding, the ability of platelet activating factor (PAF) to stimulate the release of intracellular Ca2+ pools by human neutrophils. PAF is a biologically potent phosphoacylglycerol. Inhibitors for PAF's role in the pathogenesis of inflammatory bowel disease and asthma have been sought as potential therapeutic agents. The inherent stability and protease resistance of the small, monomeric GM2 activator protein, coupled with the ability to produce large quantities of the functional protein in transformed bacteria, suggest it may serve as such an agent. |
| | |
Authors:
|
B Rigat; D Reynaud; N Smiljanic-Georgijev; D Mahuran |
Related Documents
:
|
23500724 - Np-40 reduces contamination by endogenous biotinylated carboxylases during purification... 23037174 - Naringenin inhibits the aggregation of expanded polyglutamine tract-containing protein ... 23685134 - Hiv-1 fusion protein exerts complex immunosuppressive effects. 8166364 - Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia. 6281754 - Immunohistochemical demonstration of placental protein 5 in trophoblastic tumours. 12433474 - D-glucose as a multivalent chiral scaffold for combinatorial chemistry. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Biochemical and biophysical research communications Volume: 258 ISSN: 0006-291X ISO Abbreviation: Biochem. Biophys. Res. Commun. Publication Date: 1999 May |
Date Detail:
|
Created Date: 1999-06-15 Completed Date: 1999-06-15 Revised Date: 2010-07-06 |
Medline Journal Info:
|
Nlm Unique ID: 0372516 Medline TA: Biochem Biophys Res Commun Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 256-9 Citation Subset: IM |
Copyright Information:
|
Copyright 1999 Academic Press. |
Affiliation:
|
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Calcium
/
metabolism G(M2) Activator Protein Humans Platelet Activating Factor / antagonists & inhibitors*, metabolism Protein Binding Proteins / metabolism* Spectrometry, Fluorescence |
| Grant Support | |
ID/Acronym/Agency:
|
10435//Canadian Institutes of Health Research |
| Chemical | |
Reg. No./Substance:
|
0/G(M2) Activator Protein; 0/Platelet Activating Factor; 0/Proteins; 7440-70-2/Calcium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ricin RCA60: evidence of its phospholipase activity.
Next Document: Identification of a novel kinase-like gene induced during neuronal cell death.